Regencell Bioscience Holdings Ltd (RGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RGC | AMGN | BMY | GILD | VRTX |
| Company | Regencell Bioscience Holdings Ltd | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 4.80 | 263.11 | 57.25 | 92.62 | 391.87 |
| High | 4.98 | 264.80 | 57.64 | 93.22 | 402.13 |
| Low | 4.80 | 260.87 | 56.80 | 91.79 | 390.92 |
| Last | 4.98 | 262.89 | 57.41 | 93.09 | 401.95 |
| Change | +0.06 | -0.49 | +0.08 | +0.52 | +4.68 |
| % Change | +1.22% | -0.19% | +0.14% | +0.56% | +1.18% |
| Volume | 1,862 | 1,275,273 | 3,606,201 | 1,928,039 | 1,029,663 |
| 20-Day Average Volume | 35,273 | 5,067,839 | 11,613,385 | 7,457,208 | 1,805,822 |
| Previous Close | 4.92 | 263.38 | 57.33 | 92.57 | 397.27 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 5.55 | 273.43 | 57.92 | 92.12 | 454.47 |
| 20-Day Raw Stochastic | 13.83% | 21.49% | 44.77% | 73.09% | 23.60% |
| 20-Day Relative Strength | 42.91% | 31.96% | 53.35% | 56.45% | 31.00% |
| Weighted Alpha | -90.60 | -15.37 | +19.95 | +24.65 | -10.07 |
| Today's Opinion | 88% Sell | 88% Sell | 80% Buy | 100% Buy | 72% Sell |
| Previous Opinion | 88% Sell | 88% Sell | 80% Buy | 100% Buy | 72% Sell |
| Last Month's Opinion | 40% Sell | 40% Sell | 100% Buy | 80% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.40% since 12/16/24 | -1.40% since 12/16/24 | +3.03% since 12/16/24 | +1.22% since 12/16/24 | -14.31% since 12/16/24 |
| Low | 4.72 on 12/18/24 | 253.30 on 12/19/24 | 56.05 on 12/17/24 | 90.27 on 12/19/24 | 377.85 on 12/19/24 |
| High | 5.34 on 12/19/24 | 270.26 on 12/17/24 | 58.54 on 12/18/24 | 93.59 on 12/17/24 | 474.18 on 12/17/24 |
| 1-Month | |||||
| %Chg | -15.16% since 11/22/24 | -10.79% since 11/22/24 | -2.22% since 11/22/24 | +3.30% since 11/22/24 | -11.05% since 11/22/24 |
| Low | 4.72 on 12/18/24 | 253.30 on 12/19/24 | 55.04 on 12/13/24 | 89.15 on 12/13/24 | 377.85 on 12/19/24 |
| High | 6.60 on 12/02/24 | 297.32 on 11/25/24 | 60.68 on 11/25/24 | 94.65 on 12/11/24 | 476.46 on 12/10/24 |
| 3-Month | |||||
| %Chg | -14.14% since 09/23/24 | -21.71% since 09/23/24 | +15.11% since 09/23/24 | +10.93% since 09/23/24 | -12.80% since 09/23/24 |
| Low | 4.18 on 10/08/24 | 253.30 on 12/19/24 | 49.11 on 09/25/24 | 81.83 on 09/26/24 | 377.85 on 12/19/24 |
| High | 12.50 on 10/28/24 | 335.41 on 09/24/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| 6-Month | |||||
| %Chg | +24.50% since 06/20/24 | -14.73% since 06/21/24 | +37.29% since 06/21/24 | +31.84% since 06/21/24 | -14.42% since 06/21/24 |
| Low | 3.03 on 07/22/24 | 253.30 on 12/19/24 | 39.35 on 07/05/24 | 66.01 on 07/05/24 | 377.85 on 12/19/24 |
| High | 32.44 on 07/23/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 64,024 | 141,575,456 | 116,275,392 | 115,366,840 | 102,308,544 |
| Shares Outstanding, K | 13,013 | 537,533 | 2,028,177 | 1,246,266 | 257,529 |
| Annual Sales | 0 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -4,300,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | N/A | 8,503,000,000 | 11,892,000,000 | 7,545,000,000 | 2,771,900,000 |
| Last Quarter Net Income | N/A | 2,830,000,000 | 1,211,000,000 | 1,253,000,000 | 1,045,400,000 |
| 60-Month Beta | -0.65 | 0.55 | 0.45 | 0.18 | 0.36 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 | 4.38 on 11/04/24 |
| Latest Earnings Date | 01/24/25 | 02/04/25 | 02/06/25 | 02/11/25 | 02/03/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | 0.770 on 12/13/24 | N/A |
| Next Ex-Dividends Date | 02/15/18 | 02/14/25 | 01/03/25 | 12/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.70 | 49.00 | 20.90 | 0.00 |